Trial intelligence / Profile preview

EC-MPA vs MMF in Renal Transplant Recipients With GI Symptoms

NCT00658333Phase 4Terminated

Sponsor
Novartis
Start
Mar 2008
Primary completion
Mar 2009
Countries
1
01

Overview

A Phase 4 trial of mycophenolate sodium in kidney transplant, sponsored by Novartis. Started Mar 2008; status: terminated.

02

Drugs

mycophenolate sodium
03

Conditions

kidney transplant

Beyond the preview

Go deeper on NCT00658333.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00658333.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call